SCHEMBL14508331

SCHEMBL14508331

CC1(C)c2ccccc2-c2ccc(-c3ccc4c(c3)C(C)(C)c3cc(-c5ccc6c(c5)C(C)(C)c5cc(B(O)O)ccc5-6)ccc3-4)cc21

nearest known ligand 0.41

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 16/20 0.41
MGLL Q99685 2/20 0.40
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13388829 1.00 PDK2 (0.41) PDK2MGLLCA1CA2
SCHEMBL29851086 0.94 MGLL (0.47) PDK2MGLLCA1CA2
SCHEMBL13599937 0.94 MGLL (0.47) PDK2MGLLCA1CA2
SCHEMBL24647 0.94 CA2 (0.41) PDK2MGLLCA1CA2
SCHEMBL29400267 0.94 CA2 (0.41) PDK2MGLLCA1CA2
SCHEMBL14508350 0.92 MGLL (0.37) PDK2MGLLCA1CA2
SCHEMBL1753705 0.92 MGLL (0.37) PDK2MGLLCA1CA2
SCHEMBL322572 0.91 CA1 (0.47) PDK2MGLLCA1CA2
SCHEMBL10042457 0.91 MGLL (0.53) PDK2MGLLCA1CA2
SCHEMBL30038715 0.91 MGLL (0.53) PDK2MGLLCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070122652-A1 Compound and organic electroluminescent device using same CANON KABUSHIKI KAISHA (JP) 2007-05-31 US disclosed
US-20070122652-A1 Compound and organic electroluminescent device using same CANON KABUSHIKI KAISHA (JP) 2007-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070122652-A1 Compound and organic electroluminescent device using same OR10J3, LEF1, RPL19 PDK2 3230/4885MGLL 2273/4885CA1 3092/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.